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ABSTRACT: Fibrous scaﬀolds have shown promise in tissue engineering
due to their ability to improve cell alignment and migration. In this paper,
poly(ε-caprolactone) (PCL) ﬁbers are fabricated in diﬀerent sizes using a
microﬂuidic platform. By using this approach, we demonstrated considerable
ﬂexibility in ability to control the size of the ﬁbers. It was shown that the
average diameter of the ﬁbers was obtained in the range of 2.6−36.5 μm by
selecting the PCL solution ﬂow rate from 1 to 5 μL min−1 and the sheath ﬂow
rate from 20 to 400 μL min−1 in the microﬂuidic channel. The microﬁbers
were used to create 3D microenvironments in order to investigate growth and
diﬀerentiation of adult hippocampal stem/progenitor cells (AHPCs) in vitro.
The results indicated that the 3D topography of the PCL substrates, along
with chemical (extracellular matrix) guidance cues supported the adhesion,
survival, and diﬀerentiation of the AHPCs. Additionally, it was found that the
cell deviation angle for 44−66% of cells on diﬀerent types of ﬁbers was less than 10°. This reveals the functionality of PCL
ﬁbrous scaﬀolds for cell alignment important in applications such as reconnecting serious nerve injuries and guiding the direction
of axon growth as well as regenerating blood vessels, tendons, and muscle tissue.
1. INTRODUCTION
Tissue engineering is an interdisciplinary area that combines
engineering and biology in order to improve or replace
biological functions.1,2 This area can be equipped by micro-
fabrication methods, which are powerful tools with extremely
high potential to handle some of the obstacles in tissue
engineering.3 In most applications, scaﬀolds are made of
biomaterials and applied in order to provide a suitable 3D
environment with intentions toward controlling cell behavior,
such as adhesion, proliferation, diﬀerentiation, migration,
alignment, and in providing eﬃcient nutrient transport as
well as suﬃcient mechanical properties.4,5 However, there are
some challenges in tissue engineering; the biomaterial must be
compatible with the cells in question in order to sustain
reasonably normal behaviors. As such, it is essential to gain a
better understanding of the microenvironmental conditions
required to regulate the cells fate. Additionally, tissue
engineering suﬀers from a lack of biomaterials with desirable
biological, chemical, and mechanical properties.4 To meet this
need, enormous eﬀorts have been made to discover new
biomaterials and to study the biocompatibility and biodegrad-
ability of diﬀerent materials.6,7
A prominent area of tissue engineering is related to
regenerative medicine and neurorepair. The discovery of
eﬀective therapeutic interventions targeted toward neuro-
degenerative conditions and nerve injuries has proven
challenging. Scientists and engineers have been drawn into
the ﬁeld of neural tissue engineering due to its importance for
development of novel therapeutic strategies. For example,
peripheral nerve regeneration is a complicated phenomenon
which is often successful as long as the injuries are small. With
more severe nerve injuries such as a nerve gap, however,
interposition of a nerve graft or nerve regeneration conduit is
usually required. Complexity in spinal cord injury is more
serious since, for the most part, regeneration is prohibited.
Fortunately, neural tissue engineering provides extraordinary
promise to combat this central nervous system (CNS) injury.8
For example, Hurtado et al. demonstrated axonal regeneration
within a spinal cord injury using aligned poly-L-lactic acid
microﬁbers.9 Microﬁbers may provide a supportive environ-
ment for a recovering nervous system due to the combination
of physical and biological cues.
Microﬁbers have been fabricated for neural tissue engineering
using diﬀerent approaches such as microﬂuidics, electro-
spinning, and wet spinning.10−19 Agarwal et al. reported some
of the studies in electrospinning ﬁber fabrication technique for
biomedical applications such as tissue engineering and drug
delivery.20,21 Polycaprolactone (PCL) is one of the biocompat-
ible and biodegradable polymers applied for the ﬁbers
fabricated in this technique.21−30 Schnell et al. showed that
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using electrospun PCL and collagen/PCL ﬁbers can signiﬁ-
cantly improve the attachment, migration, and neurite
orientation of Schwann cells.21 In addition to PCL, other
biocompatible polymers have been used in nerve tissue
engineering such as gelatin and polylactic acid (PLA).16,17
However, accurately aligning the ﬁbers in electrospinning
method is diﬃcult.16,22,31 This method is not functional for cell
encapsulating purposes due to the fact that the size of the ﬁbers
are mostly limited to nanoscales. Furthermore, high voltages
(5−50 kV) need to be applied for pulling the charged solution,
which might damage sensitive biological materials.32 Wet
spinning method has been employed in nerve tissue engineer-
ing as well. Siriwardane et al. fabricated collagen ﬁbers and
treated them by cross-linkers glutaraldehyde and genipin in
order to improve the mechanical properties and decrease
swelling.15 In wetspinning, the sample is exposed to chemicals
and osmotic gradients for a relatively long time, which can have
detrimental eﬀects on the cells.33,34 Additionally, the cross
section of the ﬁbers made by electrospinning and wetspinning
are mostly round due to the surface tension in the two-phase
systems of liquid/air and immiscible liquid/liquid, respec-
tively.35
Microﬂuidics is an interdisciplinary ﬁeld that has received
much attention, mostly because of its wide applications from
energy systems to biomedical areas.36−39 Microﬂuidic ﬁber
fabrication, which is the newest approach, retains most
advantages of other ﬁber fabrication approaches and minimizes
some of their shortcomings. One of the important features of
using microﬂuidic ﬁber fabrication is the compatibility with
cells, proteins, drugs, and peptides as well as versatility, cost-
eﬀectiveness, and simplicity.5,40−42 In this method, there is no
need to apply high temperature, high pressure, and high
voltages.5,40,43−46 This approach makes it feasible to fabricate
ﬁbers with diﬀerent shapes of solid,13,47−50 tubular,51,52
hybrid,31 and ﬂat14,53,54 dimensions for divergent applications
such as cell encapsulation, alignment, and immobilization.
In terms of material, there are both synthetic and natural
biodegradable and biocompatible polymers. We used PCL, a
synthetic polymer, in this study. Synthetic polymers have some
advantages over the natural materials. For example, the polymer
composition can be accurately controlled such that a wide
range of properties is obtainable for the synthetic polymers. In
addition, they are more uniform with suﬃcient source of raw
materials.55,56 Comparing with other synthetic polymers, such
as PLGA, PCL has slower degradation rate, which makes it less
acidic during degradation and desirable for long-term
implantable devices. Although some studies focused on using
the PCL electrospun ﬁbrous scaﬀolds in nerve tissue engineer-
ing, there is no report on employing hydrodynamic focusing
(microﬂuidic approach) and solvent extraction to fabricate
biocompatible PCL ﬁbers in nerve regeneration tissue
engineering.57−59 In this paper, we show that microﬂuidic
ﬁber fabrication may be used as a scalable and widely accessible
alternative technique to fabricate PCL ﬁbrous scaﬀolds with
tuned characteristics to enhance the growth and diﬀerentiation
of neural stem cells as well as neurite orientation. We cultured
green ﬂuorescent protein-expressing (GFP) adult hippocampal
stem/progenitor cells (AHPCs) on PCL microﬁbers and
investigated their ability to adhere, survive, proliferate and
diﬀerentiate. AHPCs were used because of their ability to
diﬀerentiate into the fundamental cells of the CNS. In order to
study CNS regeneration therapies, it is important to consider
the population of cells needed for repair of a damaged nervous
system. The AHPCs were maintained in medium supplemented
with bFGF and upon growth factor withdrawal, these
multipotent AHPCs diﬀerentiated into neurons and glial
cells.60,61 Neurons are able to transmit information and are
the key cells of the nervous system, whereas glial cells serve as
the support cells of the CNS. The microﬂuidic microfabrication
platform was able to create a biocompatible scaﬀold out of
ﬁbers to provide a desirable growth environment for the neural
stem cells. We showed that the cells attach to and align
themselves on the microﬁber substrates. In this study, cell death
was minimal, and cell proliferation was aﬀected by changing the
features of the ﬁbrous scaﬀold. Ideally, as the scaﬀold is
degraded a more natural microenvironment is created by the
cells and the production of their extracellular matrix (ECM),
thus resulting in a bioengineered 3D network that mimics the
native tissue.
2. EXPERIMENTAL SECTION
Materials. Poly(ε-caprolactone) (PCL) (Mn = 80 000), poly-
ethylene glycol (PEG) (Mn = 20 000), and ethanol were purchased
from Sigma-Aldrich (St. Louis, MO). 2,2,2-Triﬂuoroethanol (TFE),
which is the solvent for PCL, was obtained from Oakwood Chemical
(West Columbia, SC).
Microﬂuidic Channel. A SU8 photoresist-patterned silicon wafer
was applied as a mold and the channel was made using soft
lithography. We used two silicon wafers in order to create the pattern
of the microchannel and the chevron grooves extended from two sides
of the channel. The dimensions of the microchannel are 130 μm × 390
μm (height × width). The microchannel has four diagonal grooves
with dimensions of 130 μm × 100 μm (height × width) and are
spaced 200 μm apart. Polydimethylsiloxane (PDMS), which is a
biocompatible and transparent elastomer, was made from the mixture
of Sylgard 184 elastomer base and cross-linker agents in a 10:1 ratio.
Then, the mixture was poured onto the mold, and cured with the
temperature of 85 °C for 25 min. After that, the PDMS layer on the
silicon wafers were peeled oﬀ and the layers were bonded together
using plasma treatment.
Microﬂuidic Fiber Fabrication. The 5 wt % PCL solution (core
ﬂuid) was obtained by mixing 1 g of PCL in 20 mL TFE at room
temperature. The sheath solution was prepared by adding 1 g of PEG
in 20 mL mixture of ethanol and deionized (DI) water with a volume
ratio of 1:1 to prepare 5 wt % PEG solution. These two solutions were
introduced into the microchannel via a double syringe pump (Cole-
Parmer, Veron Hillss, IL) with diﬀerent ﬂow rate ranges of 2−5 μL
min−1 and 10−120 μL min−1 for the core and sheath solution,
respectively. Using this method, the ﬁbers remain aligned after
fabrication. The microchannel was vertically positioned into a water
bath, and the resulting ﬁbers were gathered around a paper frame in an
aligned manner (Figure S1a).
Cell Culture. Adult hippocampal progenitor cells (AHPCs) were
originally isolated from adult Fischer 344 rats and infected with a
retrovirus to express green ﬂuorescence protein (GFP) as described
previously and were a generous gift from F. H. Gage (Salk Institute for
Biological Sciences, La Jolla, CA).62 Cells were grown in ﬂasks coated
with poly-L-ornithine (10 μg mL−1; Sigma-Aldrich) and puriﬁed
mouse laminin (5 μg mL−1; R&D Systems) in Earle’s balanced salt
solution (EBSS). Maintenance media (MM) included Dulbecco’s
modiﬁed Eagle’s medium/Ham’s F-12 (DMEM/F-12, 1:1; Omega
Scientiﬁc), supplemented with 2.5 mM L-glutamine, N2 supplement
(Gibco BRL), and 20 ng mL−1 basic ﬁbroblast growth factor (human
recombinant bFGF; Promega Corporation). The AHPCs were
detached from ﬂasks using 0.05% trypsin−EDTA (Gibco BRL) and
harvested by centrifugation at 800 rpm for 5 min. A hemocytometer
was used to perform a Trypan Blue viable cell count, and AHPCs were
plated at a density of 10 000 cells/cm2 on PCL-microﬁber substrates
(see below). Cells were maintained at 37 °C in a 5% CO2/95%
humidiﬁed air atmosphere. For cell diﬀerentiation, AHPCs were
cultured in growth medium lacking bFGF (referred to as diﬀer-
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entiation medium, DM) for 7 days. Half of the media was changed
every other day.
Substrate Preparation. Glass coverslips (12 mm, Fisher
Scientiﬁc) were cleaned using RBS 35 (Thermo Scientiﬁc) detergent
diluted (1:50) in deionized water and boiled for 15 min. Coverslips
were then rinsed in DI water, air-dried and ultraviolet light was used
for sterilization. The microﬁbers were then attached to the coverslips
using medical adhesive. Small droplets of medical adhesive were placed
Scheme 1a
a(a) Schematic of the microﬂuidic ﬁber fabrication. (b) Streamline and velocity (m s−1) of the ﬂuids along the channel. (c) Illustration of
concentration proﬁle (mol m−3): the dark and bright colors represent the sheath and core ﬂuids, respectively. (d) Phase inversion process: the TFE
molecules are replaced with the molecules of the sheath ﬂuid, which results in PCL solidiﬁcation. (e) Cell culture procedure: (I) Sterilization of
microﬁbers on coverslips using 70% ethanol for 20 min; (II) diluted ECM substrate (ECL) in DMEM/F-12 to a ﬁnal concentration of 10 μg mL−1;
(III) culture AHPCs in T-75 ﬂask until 80% conﬂuent; (IV) apply trypsin to cells for collection; and (V) culture cells on ECL-coated microﬁbers in
diﬀerentiation media for 7 days.
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at opposite sides of the coverglass and a parallel array of microﬁbers
placed across the coverglass and attached to the medical adhesive
droplets. Small chip of coverglass were then used to secure the
microﬁbers to the coverglass. The microﬁbers were ﬁxed at opposite
ends and loose across the middle of the coverglass (Figure S1b). The
coverglass and PCL-microﬁber substrates were sterilized by incubation
in 70% ethanol for 20 min and rinsed with Earle’s balanced salt
solution (EBSS; Invitrogen). After 10 min of air-drying, the microﬁber
substrates were incubated at 4 °C overnight with Entactin-Collagen
IV-Laminin (ECL; Millipore) at 10 μg mL−1 in DMEM/F-12 to
facilitate cell attachment. The next day, the ECL was removed, samples
were rinsed with EBSS, and cells plated.
Immunocytochemistry. After 7 days of culturing in DM, the cells
were rinsed with 0.1 M phosphate (P04) buﬀer and immediately ﬁxed
with 4% paraformaldehyde (PFA) in 0.1 M P04 buﬀer for 20 min at
room temperature. PFA was removed and rinsed with phosphate
buﬀer saline (PBS; Invitrogen) and incubated in blocker solution (PBS
supplemented with 5% normal donkey serum (Jackson ImmunoR-
esearch), 5% normal goat serum (Jackson ImmunoResearch), 0.4%
bovine albumin serum (Sigma), and 0.2% Triton X-100 (Fisher
Scientiﬁc)) at room temperature for 1 h. Primary antibodies (see
Table S1 for list of primary antibodies) were diluted in blocker
solution and samples incubated at 4 °C overnight. On the following
day, antibodies were removed and samples were rinsed with PBS.
Secondary antibodies, donkey anti-rabbit Cy3 and donkey anti-mouse
Cy3 (Jackson ImmunoResearch), were diluted in blocking solution at
a dilution of 1:500 along with the nuclear stain, DAPI (1:50,
Invitrogen). Samples were incubated in secondary antibody/DAPI
solution for 90 min at room temperature. Samples were then mounted
on microscope slides using DAPI Fluoromount-G (Southern Biotech)
mounting media and stored at 4 °C until imaging.
Propidium Iodide Staining. Propidium iodide (PI) was used to
measure cell death/survival at 7 days in vitro. Propidium iodide stain
solution was prepared at a concentration of 1.5 μM in culture medium.
Half of the samples served as the positive, reagent control for the PI
stain and subjected to 70% ethanol for 5 min to induce cell death. The
ethanol and MM were removed from all samples and the culture
media containing PI was added for 20 min at 37 °C in a 5% CO2
incubator. The samples were then rinsed with 0.1 M P04 buﬀer, ﬁxed
with 4% PFA, and rinsed again with PBS. Samples were then incubated
with DAPI (1:50) diluted in blocker solution for 1 h at room
temperature. Following PBS rinses, samples were mounted on
microscope slides using DAPI Fluoromount-G mounting media and
stored at 4 °C until imaging.
Imaging and Measuring the Alignment Angles. Fluorescent
images were conducted using a ﬂuorescence microscope (Nikon
Microphot FXA, Nikon, Inc.), equipped with a Retiga 2000R digital
camera controlled by QCapture software (QImaging). Images were
pseudocolored using Adobe Photoshop CC. Table S1 provides
information about the diﬀerent antibodies applied for studying
AHPC growth on the microﬁbers. Scanning electron microscopy
(SEM; JCM-6000 NeoScope Benchtop scanning electron microscope)
was applied to study the size, morphology, and deviation angle of the
ﬁbers and cells. In order to acquire high quality SEM images, the
substrates were made conductive using gold sputter-coating. The
coating thickness of the samples was around 50 nm. The cell and ﬁber
deviation angles were measured using the SEM images and ImageJ,
which is an imaging analysis software. For the ﬁber size and deviation
angle, around 30 ﬁbers were studied, whereas the positions of around
100 cells were evaluated relative to the ﬁber direction in each type of
ﬁber.
3. RESULTS AND DISCUSSION
Two ﬂuids, i.e., the core and sheath ﬂuids, are introduced into
the microchannel and diﬀusion occurs only at the core/sheath
ﬂuid interface due to the laminar ﬂow regime. In order to have
a continuous ﬁber fabrication process, a core/sheath ﬂow
proﬁle is required.5 Scheme 1a provides a schematic picture of
the microﬂuidic ﬁber fabrication. The sheath ﬂuid focuses the
core ﬂuid laterally after the two ﬂuids are introduced at the
upstream of the channel and changes the shape of the core ﬂuid
to a thin vertical strip. Chevron grooves in the downstream of
the channel decrease the hydrodynamic resistance perpendic-
ular to the ﬂow direction. The sheath ﬂow rate is higher than
the core ﬂow rate in order to provide the force needed to keep
the core ﬂuid at the center of the microchannel. Because the
hydrodynamic resistance is inversely proportional to ﬂow rate,
the sheath ﬂuid ﬁlls the grooves, wraps around the core ﬂuid,
and pushes it to the center of the channel.63−65 The streamline
and velocity distribution of the ﬂuids along the channel are
provided in Scheme 1b. Scheme 1c demonstrates the
concentration proﬁle through the channel. The dark and bright
colors show the sheath and core ﬂuids, respectively. These
ﬁgures clearly illustrate the role of the sheath ﬂuid and chevron
grooves to exert the lateral and vertical hydrodynamic focusing
forces on the core ﬂuid. The lateral and vertical hydrodynamic
focusing forces, which are originated from the shear force
between the core and sheath ﬂuids, play a pivotal role to keep
the core ﬂuid at the center, align the polymer chain, and change
the shape of the microﬁbers. The hydrodynamic force depends
on the viscosity and relative velocity of the core and sheath
ﬂuids. By adding polyethylene glycol (PEG) to the sheath ﬂuid,
Figure 1. SEM images of the microﬂuidic spun PCL microﬁbers at
diﬀerent sheath-to-core ﬂow rates of (a) 20:5, (b) 60:5, (c) 200:4, (d)
300:2, and (e) 400:1. The concentrations of the PCL and PEG are 5%
in TFE and water/ethanol, respectively.
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the viscosity of core and sheath solutions match and there is no
need to use high relative velocities to focus the core ﬂuid when
fabricating the ﬁbers. Additionally, there is a possibility of ﬂow
instability in the channel at high relative velocities that results in
changing the ﬂow regime to transient from laminar.
Phase inversion (solvent extraction) strategy was used to
solidify PCL and fabricate microﬁbers. In this process, 2,2,2-
triﬂuoroethanol (TFE) in the core ﬂuid is replaced by the
ethanol and water in the sheath ﬂuid at the interface between
the sheath and core solution (Scheme 1d). This exchange
results in PCL solidiﬁcation because the sheath ﬂuid is miscible
to TFE, but not solvent to PCL. Scheme 1e describes the
sterilization and cell culture protocol for AHPCs. Following the
plating of AHPCs, cells are incubated for 7 days in
diﬀerentiation media, and subsequently ﬁxed and immunola-
beled for further analysis.
Figure 1 shows the SEM images of the ﬁbers fabricated using
the ﬂow rate ranges of 1−5 μL min−1 and 20−400 μL min−1
corresponding to the core and sheath ﬂuids, respectively. The
concentration of the PCL in TFE and PEG in the water/
ethanol were kept at a constant value of 5%. In the phase
inversion solidiﬁcation process, used to solidify the PCL ﬁbers,
the molecules of TFE are replaced by the molecules of the
sheath ﬂuid. Due to this diﬀusion at the ﬂuid/ﬂuid interface, the
surface of the PCL ﬁbers are not smooth, which could provide a
better environment for the cells to adhere to the surface of the
ﬁbers. Additionally, this ﬁgure shows consistency with the
theory of hydrodynamic focusing meaning that when the ﬂow
rate ratio between the core and sheath ﬂuids decreases, the
shear force at the interface exerted from the sheath ﬂuid to the
core ﬂuid weakens. Therefore, the core ﬂuid extends in the
channel and the size of the resulting ﬁber increases. This ﬁgure
also demonstrates that once the ﬂow rate ratio exceeds 50, the
ﬁbers will not be smooth anymore. This condition continues
until the wavy ﬁbers connect with each other and create a chain,
that could be considered as a self-assembly structure (Figure
1e). This was expected because when the ﬂow rate ratio
between the ﬂuids increases, the sharp velocity gradient at the
ﬂuid/ﬂuid interface intensiﬁes the shear force, which decreases
the ﬂow stability and the regime starts to lie in the transition
region.45 The average size and production rate of the ﬁbers
(mean ± standard error) are shown in Figure 2a and b,
respectively. The results show that the diameters of the ﬁbers
lie in the range of 2.6−36.5 μm, which can be obtained by
changing the sheath-to-core ﬂow rate of 400:1−20:5,
respectively. This ﬁgure demonstrates the capability of the
Figure 2. Characteristics of the PCL microﬁbers: (a) size, (b) production rate, and (c) alignment of the ﬁbers fabricated using diﬀerent sheath-to-
core ﬂow rate ratios.
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microﬂuidic ﬁber fabrication in tuning the size of the ﬁbers by
simply changing the ﬂow rate ratio between the sheath and core
ﬂuids. As expected, the production rate of the ﬁber directly
depends on the sheath and core ﬂow rates. The maximum
production rate was 37 mm s−1 for the sheath-to-core ﬂow rates
of 400:1, and it decreases to 6.5 mm s−1 when the sheath-to-
core ﬂow rate of 60:5 is used. However, it does not mean that
the range of the production rate in microﬂuidic approach is
limited. We can increase the production rate by increasing the
sheath and core ﬂow rates. However, in this study, we mostly
focused on studying the alignment of the AHPCs on ﬁbers with
diﬀerent sizes. The small error bars reveal the uniformity of the
Figure 3. Proliferation and survival of AHPCs cultured on PCL microﬁbers. Fluorescence images of AHPCs immunolabeled for Ki-67, cell
proliferation marker (A−C) or propidium iodide (PI) staining. Middle column of images illustrate GFP-expressing AHPCs (B, E, and H). As a
control for the PI staining reagents, samples were subjected to ethanol (EtOH) treatment that causes most cells to die resulting in extensive PI-
staining (G, H, and I). Merged images (C, F, and I) of antibody labeling or PI-staining (red) with GFP-expression (green) and DAPI nuclei
counterstaining (blue). Scale bar = 100 μm.
Figure 4. Attachment and diﬀerentiation of AHPCs cultured on PCL microﬁbers. Fluorescence images of AHPCs immunolabeled for nestin (A−C),
TuJ1 (D−F), and MAP2ab (G−I). Middle column of images illustrate GFP-expressing AHPCs (B, E, and H). Merged images (C, F, and I) of
antibody labeling (Cy3, red) with GFP-expression (green) and DAPI nuclei counterstaining (blue). Asterisks indicate the location of the higher
magniﬁcation inset images in (A), (D), and (G). Attachment of cells is seen through immunolabeling of processes around microﬁbers. Scale bar =
100 μm (200 μm for insets).
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size and production rate of the ﬁbers made by this method.
Figure 2c illustrates the alignment of diﬀerent types of ﬁbers by
presenting the percentage of ﬁber deviation angle, i.e., the angle
between each one of the ﬁbers and a reference. This ﬁgure
shows that the percentage of the ﬁbers with ﬁber deviation
angle larger than 10° are 5.55%, 0%, 0%, 2.38%, and 6.1% for
the sheath-to-core ﬂow rates of 20:5, 60:5, 200:4, 300:2, and
400:1, respectively. This shows one of the advantages of
microﬂuidic approach over common ﬁber fabrication methods,
which is the feasibility of this method to simply fabricate the
aligned ﬁbers.
Ki-67 immunolabeling was used to evaluate whether the PCL
microﬁbers would support proliferation of the AHPCs.
Expression of the Ki-67 antigen occurs during the cell cycle
(not detected in cells in the resting phase) and therefore is
commonly used as a cellular marker for cell proliferation. Ki-67
immunolabeled cells were present on all microﬁbers examined.
Figure 3A−C illustrates an example of Ki-67 immunolabeled
cells growing on microﬂuidic spun PCL microﬁbers at a sheath-
to-core ﬂow rate of 60:5. The results of proliferation of AHPCs
on all types of fabricated ﬁbers are provided in Figure S2.
Propidium iodide staining was used to evaluate survival of
AHPCs growing on the microﬁbers (Figure 3D−I). Propidium
iodide is a ﬂuorescent nuclear and chromosome counterstain
that is membrane impermeant and commonly used to identify
dead cells in a population.
Figure 3D−F shows that very few PI-positive cells were
detected in the microﬁber cultures. In contrast, as a positive
control for the PI reagents, some samples were subjected to
70% ethanol, a condition that kills most cells, resulting in the
majority of cells PI-labeled (Figure 3G−I). It is notable that the
cells remained attached following the 70% ethanol treatment.
This is likely due in part to the immediate ﬁxation in
paraformaldehyde. Furthermore, the ECL substrate absorption
onto the PCL microﬁbers facilitates cell attachment. Taken
together, the Ki-67 immunolabeling and Propidium Iodide
staining results indicate that the diﬀerent PCL microﬁbers
produced by the diﬀerent sheath-to-core ﬂow rates all
supported adhesion and cell proliferation, and did not
dramatically aﬀect cell viability.
AHPCs growing on the diﬀerent PCL microﬁbers were
characterized morphologically and immunocytochemically
using a panel of cell-type speciﬁc antibodies (Table S1). The
AHPCs are a multipotent population of adult neural stem cells
and have the capacity to diﬀerentiate into neurons, oligoden-
drocytes and astrocytes.61 The phenotypes of AHPCs growing
on the microﬁbers were assessed using antibodies directed
against nestin, an intermediate ﬁlament protein present in
neural stem/progenitor cells; class III β-tubulin (TuJ1), a
protein characteristic of early neurons; microtubule-associated
protein 2ab (MAP2ab), characteristic of maturing neurons; and
the glial markers, receptor interacting protein (RIP) and glial
ﬁbrillary acidic protein (GFAP), for oligodendrocytes and
astrocytes, respectively. AHPCs were identiﬁed in culture based
on green ﬂuorescent protein GFP-expression and counter-
staining with DAPI allowed visualization of the cell nuclei.
Many of the AHPCs were immunolabeled with the nestin, TuJ1
and MAP2ab antibodies (Figure 4), fewer cells were
immunoreactive for the glial markers RIP and GFAP (Figure
S3). Figure 4 illustrates examples of AHPCs growing on
microﬂuidic spun PCL microﬁbers at a sheath-to-core ﬂow rate
of 300:2 that were immunolabeled with the nestin (Figure 4A−
C), TuJ1 (Figure 4D−F), or MAP2ab (Figure 4G−I)
antibodies. Nestin, a marker for multipotent neural stem cells,
has important functions in the survival and self-renewal of
NSCs. AHPCs immunolabeled for nestin indicates that many of
the cells growing on the PCL microﬁbers retained their
progenitor-like status. Under diﬀerentiation conditions (ini-
tiated by growth factor withdrawal) AHPCs begin diﬀer-
entiating and many cells were immunolabeled with the
neuronal markers TuJ1 and MAP2ab. Immunolabeled cells
displayed neuronal morphologies, often exhibiting longer
neurites of various lengths on the microﬁber surface. Though
all three antibody markers (nestin, TuJ1, and MAP2ab) label
diﬀerent cytoskeletal elements, all are expressed within the
cytoskeleton of the neurite processes as was clearly evident in
the ﬂuorescent images (Figure 4). It was noted that some of the
AHPCs undergo a decrease in expression of GFP during the
course of cell culture, indicating a down regulation of the GFP
transgene during the course of establishment of stable cell
populations that allow long-term culture. However, these low
GFP expressing AHPCs continued to survive, proliferate, and
diﬀerentiate in a normal fashion.
The SEM images of AHPCs on the PCL microﬁbers are
shown in Figure 5. This ﬁgure illustrates that most of the cells
can be aligned to the longitudinal direction of the ﬁbers with
Figure 5. SEM images of the AHPCs growing on PCL microﬁbrous
scaﬀolds fabricated by using diﬀerent sheath-to-core ﬂow rates of (a)
20:5, (b) 60:5, (c) 200:4, and (d) 300:2. PCL and PEG concentrations
are 5% in TFE and water/ethanol, respectively.
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diﬀerent sizes. This reveals the role of the ﬁbers as scaﬀolds to
be applied for supporting the proliferation and diﬀerentiation of
AHPCs. However, the ﬁbers with larger sizes can physically
support more cells on their surfaces compared to smaller ones.
The SEM images with higher magniﬁcations are provided in
Figure 6a−e. In terms of the size of the aligned PCL ﬁbers, this
ﬁgure shows that while the predominant alignment of the cells
is in the axial direction of the ﬁbers, the cells on ﬁbers with the
average size of 4−7 μm on occasion bridged from one ﬁber to
another one (Figure 6d). The likely reason for such behavior is
that the distance between the thinner ﬁbers is shorter and that
bundles of ﬁbers have been created. As a result, the cell can
bridge between two ﬁbers. However, Figure 6e demonstrates
that this behavior is not observed for the thinnest ﬁber. That is
because the ﬁbers are wavy (Figure 1e) due to the large velocity
diﬀerence between the core and sheath ﬂuids and resulting
instability. It is possible that when placed in cell culture, the
ﬁbers become braided such that it is more diﬃcult to separate
the ﬁbers from each other. When the ﬁbers with the ﬂow rate
ratio of 400:1 are braided, a uniform bundle is created which
allows more cells to attach on the surface due to increase
surface area. Additionally, the empty space between the ﬁbers
may mimic a 3D microenvironment for the cells in order to
allow nutrients to be exchanged to increase survival of cells. It
can be observed that although this type of ﬁber are wavy and
develop in diﬀerent directions, the ultimate direction of all of
Figure 6. (a−e) SEM images of the AHPCs cultured on the PCL microﬁbers. (f) Illustration of cell deviation angle. (g) Quantiﬁcation of the neurite
orientation on the ﬁbers.
Biomacromolecules Article
DOI: 10.1021/acs.biomac.6b01028
Biomacromolecules 2016, 17, 3287−3297
3294
the ﬁbers are in the same direction. However, it was reported
that the mechanical properties of the PCL ﬁbers decrease with
increasing ﬂow rate ratio.45 Therefore, if high mechanical
properties are required, larger ﬁbers are better choices for the
PCL ﬁbrous scaﬀolds that provide enough strength as well as a
desirable microenvironment for aligning the cells. The neurite
orientation on the ﬁbers was analyzed quantitatively based on
SEM images by measuring the cell deviation angle, which is the
angle between the main axis of the cells and the ﬁbers (Figure
6f). The results of measuring the cell deviation angle are shown
in Figure 6g. This ﬁgure demonstrates that the cell deviation
angle is mostly less than 10° for ﬁbers with diﬀerent sizes,
which reﬂects that the PCL microﬁbers were able to align the
AHPCs eﬃciently along their axial directions. The percentage
of the cells with deviation angle lower than 10° is 61%, 53%,
63%, 44%, and 66% for the ﬁbers fabricated using the sheath-to-
core ﬂow rate ratio of 20:5, 60:5, 200:4, 300:2, and 400:1,
respectively. The percentage of the cells with deviation angle
larger than 10° decreases signiﬁcantly. However, number of the
cells with the cell deviation angle in the range of 70−90°
increases to the maximum values of 29% and 35% on the ﬁbers
made by the sheath-to-core ﬂow rate of 200:4 and 300:2,
respectively due to cells bridging within the bundles of
microﬁbers.
4. CONCLUSION
Aligned PCL microﬁbers with diﬀerent features were fabricated
in this study using microﬂuidic ﬁber fabrication. The mean
diameter of the fabricated ﬁbers ranged from 2.6 to 36.5 μm by
selecting the sheath-to-core ﬂow rate ratio from 400:1 to 20:5.
The mean deviation angles (±standard error) were found 3.95
± 0.70, 4.64 ± 0.51, 3.84 ± 0.50, 4.39 ± 0.54, and 4.88 ± 0.62
for the sheath-to-core ﬂow rates of 20:5, 60:5, 200:4, 300:2, and
400:1, respectively. The ﬁbers were coated with a complex
extracellular matrix substrate via physical absorption to facilitate
cell attachment and for guiding the direction of AHPC growth
in vitro. The results showed that the PCL ﬁber can be used as a
ﬁbrous scaﬀold which is not cytotoxic to the AHPCs, and
supports cell adhesion, diﬀerentiation, and proliferation.
Additionally, it was shown that the clusters of these adult
neural stem cells can be aligned using the PCL microﬁbers. The
quantitative analysis demonstrated that the cell deviation angle
for most of the cells guided by diﬀerent types of ﬁbers was less
than 10°. On average, 58% of the cells in all types of the ﬁbers
had a cell deviation angle less than 10°, revealing the
functionality and potential of the PCL microﬁbers for guiding
nerve regeneration within the central (CNS) and peripheral
nervous system (PNS) and may facilitate repair of spinal cord
injuries (SCI) and peripheral nerve injuries (PNI). This
integration of multiple cues within a 3D context is important
for gaining a better understanding in regulating neural stem cell
diﬀerentiation and in designing scaﬀolds for neural tissue
engineering. We are currently implanting bundles of PCL
microﬁbers into conduits, and the preliminary results suggest
that this approach may aid in regeneration of severed nerve
injuries. By mimicking the microenvironment of the nervous
system, regeneration can be enhanced due to biological and
chemical cues in the environment. Using conduits with PCL
microﬁber bundles can be investigated for various regeneration
strategies including central nervous system diseases in order to
repair a damaged system. In addition, the PCL ﬁbers can be
applied in regeneration of other tissues such as muscle,
tendons, and blood vessels.
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